603707.SH
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 7.78
−2.26%Next report
Analyst consensus
- Next report date
- Oct 26, 2026
- EPS estimate
- CNY 0.08
- Revenue estimate
- CNY 998.8M
Latest reported
- Last report date
- Aug 27, 2026
- EPS actual
- CNY 0.06
- EPS estimate
- CNY 0.15
- Revenue actual
- CNY 987.4M
- Revenue estimate
- CNY 998.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -58.9%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 27, 2026 | CNY 0.15 | CNY 0.06 | Miss -58.89% | CNY 987.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 26, 2026